Table of Content

1. US Cancer Antibodies Market Analysis
1.1 Overview
1.2 Current Market Scenario
1.3 US - Leading Cancer Antibodies


2. US Cancer Antibodies Market Segmentation by Therapeutic Class
2.1 Immune Checkpoint Inhibitors
2.2 US Bispecific Antibody Market
2.3 US Antibody Drug Conjugate Market
2.4 Other Cancer Antibody Therapeutics
2.4.1 VEGF/VEGFR Inhibiting Antibodies
2.4.2 CD20 Targeting Antibodies
2.4.3 CD38 Targeting Antibodies
2.4.4 EGFR Inhibiting Antibodies


3. US Breast Cancer Antibodies Market
3.1 Current Market Scenario
3.2 Leading Breast Cancer Antibodies


4. US Blood Cancer Antibody Market
4.1 Current Market Scenario
4.2 Leading Blood Cancer Targeting Antibodies


5. US Lung Cancer Antibody Market
5.1 Current Market Scenario
5.2 Leading Antibodies for Lung Cancer


6. US Colorectal Cancer Antibodies Market Overview



7. US Cancer Biosimilar Market
7.1 Current Market Scenario
7.2 Market Opportunity & Future Forecast


8. Global Peptide Cancer Therapeutics Clinical Trials Overview
8.1 By Company
8.2 By Indication
8.3 By Patient Segment
8.4 By Phase


9. US HER2 Inhibiting Antibodies - Availability, Dosage, Patent, Price & Sales Analysis
9.1 Trastuzumab (Herceptin)
9.2 Trastuzumab Biosimilar (Ontruzant)
9.3 Trastuzumab Biosimilar (Ogivri)
9.4 Trastuzumab Biosimilar (Herzuma)
9.5 Trastuzumab Biosimilar (Trazimera)
9.6 Trastuzumab Biosimilar (Kanjinti)
9.7 Trastuzumab & Hyaluronidase Injection (Herceptin Hylecta)
9.8 Pertuzumab (Perjeta)
9.9 Margetuximab (Margenza)


10. US VEGF/VEGFR Inhibiting Antibodies -Availability, Dosage, Patent, Price & Sales Analysis
10.1 Bevacizumab (Avastin)
10.2 Bevacizumab Biosimilar (Mvasi)
10.3 Bevacizumab Biosimilar (Zirabev)
10.4 Ramucirumab (Cyramza)



11. US Antibody-Drug Conjugates - Availability, Dosage, Patent, Price & Sales Analysis
11.1 Ado-Trastuzumab Emtansine (Kadcyla)
11.2 Fam-Trastuzumab Deruxtecan (Enhertu)
11.3 Trodelvy (Sacituzumab Govitecan-hziy)
11.4 Moxetumomab Pasudotox-tdfk (Lumoxiti)
11.5 Inotuzumab Ozogamicin (Besponsa)
11.6 Gemtuzumab Ozogamicin (Mylotarg)
11.7 Belantamab Mafodotin-blmf (Blenrep)
11.8 Brentuximab Vedotin (Adcetris)
11.9 Polatuzumab Vedotin-piiq (Polivy)
11.10 Enfortumab Vedotin (Padcev)


12. US CD20-Directed Antibody - Availability, Dosage, Patent, Price & Sales Analysis
12.1 Rituximab (Mabthera/Rituxan)
12.2 Rituximab Biosimilar (Truxima)
12.3 Rituximab Biosimilar (Riabni)
12.4 Rituximab Biosimilar (Ruxience)
12.5 Rituximab/Hyaluronidase (Rituxan Hycela)
12.6 Obinutuzumab (Gazyva)
12.7 Ofatumumab (Arzerra)


13. US Bispecific Antibodies - Availability, Dosage, Patent, Price & Sales Analysis
13.1 Blinatumomab (Blincyto)


14. CD52 Monoclonal Antibodies - Availability, Dosage, Patent, Price & Sales Analysis
14.1 Alemtuzumab (Lemtrada)



15. CD38 Monoclonal Antibodies - Availability, Dosage, Patent, Price & Sales Analysis
15.1 Isatuximab-irfc (Sarclisa)
15.2 Darzalex (Daratumumab)
15.3 Darzalex Faspro (Daratumumab/Hyaluronidase)


16. Immune Checkpoint Inhibitor - Availability, Dosage, Patent, Price & Sales Analysis
16.1 Pembrolizumab (Keytruda )
16.2 Ipilimumab (Yervoy)
16.3 Nivolumab (Opdivo)
16.4 Durvalumab (Imfinzi) – Urothelial Carcinoma
16.5 Avelumab (Bavencio)
16.6 Atezolizumab (Tecentriq)
16.7 Cemiplimab (Libtayo)


17. EGFR Inhibitors - Availability, Dosage, Patent, Price & Sales Analysis
17.1 Cetuximab (Erbitux)
17.2 Portrazza (Necitumumab)
17.3 Nimotuzumab
17.4 Panitumumab (Vectibix)


18. Combinational Antibodies - Availability, Dosage, Price & Sales Analysis
18.1 Trastuzumab, Pertuzumab, & Hyaluronidase (Phesgo)


19. Others Cancer Targeting Antibodies of US - Availability, Dosage, Patent, Price & Sales Analysis
19.1 Tagraxofusp (Elzonris)
19.2 Tafasitamab (Monjuvi)
19.3 Mogamulizumab-kpkc (Poteligeo)
19.4 Denosumab (Xgeva)

19.5 Empliciti (Elotuzumab)
19.6 Unituxin (dinutuximab) Neuroblastoma
19.7 Satumomab
19.8 Naxitamab-gqgk (Danyelza)
19.9 Iodine I 131 Derlotuximab Biotin
19.10 Capromab Pendetide (ProstaScint)


20. Competitive Landscape
20.1 Amgen
20.2 AryoGen Pharmed
20.3 AstraZeneca plc
20.4 BIOCAD
20.5 Boehringer Ingelheim
20.6 Bristol Mayer Squibb
20.7 Daiichi Sankyo Company
20.8 Genentech
20.9 Immunomedics
20.10 Innovent Biologics
20.11 Jassen Pharmaceuticals
20.12 MacroGenics
20.13 mAbxience
20.14 Mylan
20.15 Outlook Therapeutics
20.16 Pfizer
20.17 Prestige Biopharma
20.18 Roche
20.19 Samsung Bio
20.20 Seagen